APP and Alzheimer disease: However, Nakamura et al. reported in Nature that APP/Aβ42 and Aβ40/Aβ42 ratios, detected in plasma through immunoprecipitation coupled to mass spectrometry, can predict amyloid accumulation in the brain, suggesting the diagnostic importance of these biomarkers in the AD pathogenesis [90].